Tableting Defects
Tableting Defects is a pharmaceutical formulation phenomenon characterized by unintended physical or structural deviations in compressed solid dosage forms that compromise their quality, efficacy, or manufacturability.
9
Publications
272
Citations
35
Authors
11
Institutions
Publications per year
2017–2026
4
Parents
9
Jakub Dvořák, Jan Tomáš, Denisa Lizoňová et al. · International Journal of Pharmaceutics · 2020 · 22 citations
1–5 of 9
35
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
2 publications · 103 citations
2
h-index
2
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
2 publications · 103 citations
2
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
2 publications · 103 citations
2
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
2 publications · 103 citations
2
h-index
1–5 of 35
11
Object Research Systems (Canada)
Montreal, Canada
2 h-index
5 publications
296 citations
The University of Texas at Austin
Austin, United States
2 h-index
6 publications
309 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
2 publications
103 citations

University of Chemistry and Technology, Prague
Prague, Czechia
1 h-index
4 publications
88 citations
University of Jordan
Amman, Jordan
1 h-index
3 publications
42 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
1 h-index
4 publications
160 citations
United States Military Academy
West Point, United States
1 h-index
2 publications
26 citations

Qatar University
Doha, Qatar
1 h-index
2 publications
88 citations
1–8 of 11
4 publications · 168 citations
4
h-index
2 publications · 36 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 13 citations
1
h-index
1 publications · 15 citations
1
h-index
1–5